Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- Citation:
- J Clin Oncol vol 30 (13) 1534-1540
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 692
- Children:
- None
- Pharmas:
- Grants:
- U10 CA031946, U10 CA033601, CA33601
- Corr. Author:
- Authors:
- William Kevin Kelly Susan Halabi Michael Carducci Daniel George John F. Mahoney Walter M. Stadler Michael Morris Philip Kantoff J. Paul Monk Ellen Kaplan Nicholas J. Vogelzang Eric J. Small
- Networks:
- Study
- CALGB-90401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Original Reports, Urologic Oncology